Prot #KO-MEN-001: A Phase 1/2A First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date1/15/20 → 1/15/23

Funding

  • Pharm-Olam International Ltd. (Prot #KO-MEN-001)
  • Kura Oncology, Inc. (Prot #KO-MEN-001)
View all
View less